News News July 8, 2026 Notice of Office Closure GeneDesign, Inc. – Osaka SiteRead more June 23, 2026 Notice of Appointment of Directors GeneDesign, Inc. – Osaka SiteRead more April 21, 2026 Impact of the Current Situation in the Middle East on Our Manufacturing Operations GeneDesign, Inc. – Osaka SiteRead more April 16, 2026 Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing Read more March 31, 2026 NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody–Drug Conjugate Development Read more March 2, 2026 Notice of Office Closure GeneDesign, Inc. – Osaka SiteRead more November 27, 2025 Notice of Office Closure GeneDesign, Inc. – Osaka SiteRead more November 17, 2025 Ajinomoto Bio-Pharma Services Wins “Best ADC Preclinical Publication 2024” Award for AJICAP® Technology at 2025 World ADC Awards Read more October 31, 2025 Ajinomoto Co., Inc. Enters Licensing Agreement with Astellas Pharma Inc. for Biopharmaceutical Development and Manufacturing Technology Read more October 28, 2025 Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to Advance Large-Scale Peptide and Protein Manufacturing Read more October 21, 2025 Ajinomoto Bio-Pharma Services and Gene Tools Announce Collaboration to Expand Access to PMO Therapeutics Read more May 6, 2025 Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc. Read more Loading…Load More Althea Technologies Announces Expanded Roles for Key Executives Previous Page 1 … 6 7 8